a Department of Orthopedic Surgery , Enshu Hospital , Hamamatsu, Shizuoka , Japan.
b Department of Orthopedic Surgery , Shizuoka Municipal Hospital , Shizuoka , Japan.
Endocr Res. 2019 Aug;44(3):117-125. doi: 10.1080/07435800.2019.1577892. Epub 2019 Feb 14.
: The correlation between serum levels of homocysteine and bone mineral density remains controversial. The aim of this study was to identify the potential factors associated with the levels of serum total homocysteine (S-Hcy) and urinary N-terminal telopeptide of type I collagen (U-NTX) in female osteoporotic patients. : This cross-sectional study included 163 female osteoporotic patients, aged between 48 and 91 years, who had never been treated with anti-osteoporosis therapy. Background data including spine and hip bone mineral density, ongoing therapy for the metabolic disease, aortic calcification score as evaluated by lateral lumbar X-ray film, and recent fragility fracture history were obtained. S-Hcy, U-NTX levels, and creatinine clearance were measured. : Multiple linear regression analysis revealed a significant correlation between S-Hcy levels and aortic calcification score ( = 0.022), creatinine clearance ( = 0.004), and recent fracture history (within 1 year after fracture) ( = 0.028); conversely, U-NTX levels correlated significantly with total hip bone mineral density ( < 0.0001) and recent fracture history (p = 0.0007). : S-Hcy levels had no correlation with bone mineral density, but were associated with the degree of aortic calcification, renal function, and fracture events. These confounding factors should be taken into consideration when the relationship between S-Hcy and bone mineral density is discussed.
血清同型半胱氨酸水平与骨密度之间的相关性仍存在争议。本研究旨在确定与女性骨质疏松症患者血清总同型半胱氨酸(S-Hcy)和尿Ⅰ型胶原 N 末端肽(U-NTX)水平相关的潜在因素。
这项横断面研究纳入了 163 名年龄在 48 至 91 岁之间、从未接受过抗骨质疏松症治疗的女性骨质疏松症患者。收集了背景数据,包括脊柱和髋部骨密度、代谢性疾病的当前治疗情况、通过腰椎侧位 X 光片评估的主动脉钙化评分,以及最近脆性骨折史。测量了 S-Hcy、U-NTX 水平和肌酐清除率。
多元线性回归分析显示,S-Hcy 水平与主动脉钙化评分( = 0.022)、肌酐清除率( = 0.004)和近期骨折史(骨折后 1 年内)( = 0.028)呈显著相关;相反,U-NTX 水平与全髋骨密度呈显著相关( < 0.0001)和近期骨折史(p = 0.0007)。
S-Hcy 水平与骨密度无相关性,但与主动脉钙化程度、肾功能和骨折事件有关。在讨论 S-Hcy 与骨密度之间的关系时,应考虑这些混杂因素。